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Abstract
Introduction: Prevention of acute HIV infections in pregnancy is required to
achieve elimination of pediatric HIV. Identification and support for HIV negative
pregnant women and their partners, particularly serodiscordant couples, are critical.
A mixed method study done in Southern Mozambique estimated HIV incidence
during pregnancy, associated risk factors and factors influencing partner’s HIV
testing.
Methods: Between April 2008 and November 2011, a prospective cohort of 1230
HIV negative pregnant women was followed during pregnancy. A structured
questionnaire, HIV testing, and collection of dried blood spots were done at 2–3
scheduled visits. HIV incidence rates were calculated by repeat HIV testing and risk
factors assessed by Poisson regression. A qualitative study including 37 individual
interviews with men, women, and nurses and 11 focus group discussions (n594)
with men, women and grandmothers explored motivators and barriers to uptake of
male HIV testing.
Results: HIV incidence rate was estimated at 4.28/100 women-years (95%CI:
2.33–7.16). Significant risk factors for HIV acquisition were early sexual debut (RR
3.79, 95%CI: 1.04–13.78, p50.04) and living in Maputo Province (RR 4.35, 95%CI:
0.97–19.45, p50.05). Nineteen percent of women reported that their partner had
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tested for HIV (93% knew the result with 8/213 indicating an HIV positive partner),
56% said their partner had not tested and 19% did not know their partner test
status. Of the 14 seroconversions, only one reported being in a serodiscordant
relationship. Fear of discrimination or stigma was reported as a key barrier to male
HIV testing, while knowing the importance of getting tested and receiving care was
the main motivator.
Conclusions: HIV incidence during pregnancy is high in Southern Mozambique,
but knowledge of partners’ HIV status remains low. Knowledge of both partners’
HIV status is critical for maximal effectiveness of prevention and treatment services
to reach elimination of pediatric HIV/AIDS.
Introduction
Prevention of mother-to-child transmission (PMTCT) of HIV includes preven-
tion of incident infection among women of reproductive age, especially during
pregnancy [1]. Women during pregnancy and the postpartum period have an
increased risk of acquiring HIV, similar to high-risk sub-populations, such as
female sex workers, men having sex with men and known serodiscordant couples
[2]. Therefore, strong preventive services, including identification of serodiscor-
dancy among pregnant couples is crucial to decrease HIV transmission.
Most PMTCT programs have achieved high rates of initial HIV testing, with
periodic repeat testing recommended for HIV negative pregnant women.
However, partner involvement in mother and child health (MCH) services is
mostly restricted to requests for HIV testing during antenatal care [3] with poor
uptake in sub-Saharan Africa [4–7].
Mozambique has a high HIV burden, with a national prevalence of 16% among
pregnant women and the highest prevalence (24%) occurring in Southern
Mozambique [8]. The national PMTCT program includes opt-out testing for
pregnant women, with all women encouraged to invite their partners for HIV
testing at the clinic. In the 2009 national survey on HIV prevalence, knowledge
and risk behaviors, analysis of HIV testing among couples revealed that 64%
reported neither partner had tested, 20% reported only the female partner was
tested, 5% only the male partner tested and 11% reported both partners were
tested [9]. Reasons for the low uptake of male partner testing were not assessed.
The Elizabeth Glaser Pediatric AIDS Foundation and the Instituto Nacional de
Sau´de (INS) undertook a study to estimate HIV seroconversion (defined by repeat
HIV rapid testing) and its associated factors in pregnant women in Southern
Mozambique. Knowing the HIV status of the male partner is an important factor
in decreasing the risk of incident infection during pregnancy and beyond by
providing appropriate preventive services. This factor, combined with the low
rates of partner testing, highlighted the need for a qualitative component to be
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added to the study, allowing for the exploration of motivators and barriers to the
uptake of HIV testing by male partners.
Methods
The study was conducted in six rural health facilities and their surrounding
communities in Gaza (Chibuto, Chicumbane and Malehice) and Maputo
(Marracuene, Moamba and Boane) provinces in Southern Mozambique. Facilities
were chosen by convenience because of high HIV prevalence and antenatal care
(ANC) attendance. The study used a mixed methodology with a prospective
cohort of HIV negative pregnant women attending ANC services followed during
pregnancy and a qualitative formative evaluation involving men, women,
grandmothers and health care workers (HCW) from the health facilities and
surrounding communities. Data collection was done between April 2008 and
November 2011. After delivery, women were eligible to enroll in a separate
postpartum incidence cohort [10].
Prospective Cohort Study
HIV negative pregnant women attending their first or subsequent ANC visits were
invited to participate in the cohort by a trained MCH nurse. Screening and
enrollment were done consecutively and concurrently in the six study sites until
the desired sample size was reached. Inclusion criteria were age $18 years,
gestational age #32 weeks, and a negative HIV test at enrollment. A trained study
counselor administered a structured questionnaire during three scheduled study
visits at enrollment, 28 weeks of gestational age, and delivery. The study visits were
scheduled during women’s routine antenatal care visits, while the study visit at
delivery usually happened soon after delivery. Women who enrolled between 28
and 32 weeks of gestational age participated in only two of the three study visits
(enrollment visit and delivery). Information on sexual activity, condom use, and
knowledge of partner serostatus was collected. The enrollment questionnaire
included additional questions on socio-demographic data and knowledge of HIV/
PMTCT. HIV rapid testing and collection of dried blood spots (DBS) were done
by the MCH nurse at each visit.
On site HIV testing was performed as per the national guidelines using a
sequential algorithm of two rapid tests. Screening was conducted using the
Determine HIV1/2 (Abbott Laboratories, Wiesbaden, Germany) rapid assay.
Women testing non-reactive on this first test were regarded as HIV-negative while
those with reactive results were further tested using the UniGold Recombigen
(Trinity Biotech, Co Wicklow, Ireland). Women with reactive results on both
assays were considered to be HIV-infected. Women with discordant rapid test
results were requested to return four weeks later for re-testing, as per national
guidelines. Testing procedures were conducted as per the manufacturer’s
instructions for whole blood specimens. External quality assessment of rapid
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testing was performed by the reference laboratory as part of the National Quality
Assurance Program, with proficiency panels being sent twice a year.
Women who seroconverted during the study were provided with follow up care
as per the national guidelines. Confirmatory testing for women with HIV
seroconversion was conducted on DBS samples from the last and all previous
visits using HIV DNA-PCR analysis (Roche Amplicor HIV-1 DNA Test, version
1.5, Roche Molecular Diagnostics, Branchburg NJ). All confirmatory testing and
storage of samples was done in the INS national immunology reference laboratory
in Maputo.
Based on previous studies, we assumed that the percentage of women
seroconverting during pregnancy and postpartum period is approximately 12%
[11]. Using the large sample normal approximation, a two-sided 95% confidence
interval with 2% precision for a maximum expected proportion of 0.12 requires a
sample size of 1015 pregnant women. Allowing for 10% loss to follow-up, sample
size was calculated at 1128 pregnant women.
Data were double entered in an electronic database and corrected for
discrepancies using EpiData Version 1.1. Statistical analysis was conducted using
SAS/STAT software, Version 9.2 of the SAS System for Windows (STAT Institute
Inc., Cary, NC, USA). HIV seroconversion on subsequent serological testing was
used as a proxy for calculating the HIV incidence rate. For the incidence rate
calculations, exposure time was calculated as the interval between time of
enrollment until last HIV negative test for non-seroconverters and until the time
of HIV infection for seroconverters, which was estimated as the midpoint between
the last negative HIV rapid test result and the first positive HIV rapid test result.
Bivariate analysis was done to estimate associations with seroincidence, using
Poisson regression models. P-values below 0.05 were considered statistically
significant.
Qualitative Component
In four of the six study districts (Chibuto, Chicumbane, Marracuene, Moamba),
individual interviews and focus group discussions (FGD) were conducted with
fathers, paternal grandmothers, pregnant or postpartum women, and MCH
nurses. Paternal grandmothers are important family decision makers in Southern
Mozambique as the culture is patrilineal and many men are migrant workers.
All participants were $18 years of age and had to be able to provide written
informed consent. The study population criteria included being a father; a
paternal grandmother of a child ,2 years old, a pregnant woman or mother of a
child ,2 years old; or an MCH nurse.
The interviews were done with women attending the MCH clinic, men
attending the outpatient clinic and MCH nurses in the four study health facilities.
After receiving information about the study, health care workers in antenatal,
postnatal and outpatient clinics identified potential study participants among men
and women attending these services. Clients received information about the study
during the daily health information session and if interested, were referred to the
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study team who screened for eligibility. Pregnant women did not have to part of
the cohort study to participate in the qualitative component. For the health care
workers interviews, MCH nurses who were available on the day of data collection
were invited by study staff to participate. All interviews were held in a private
room at the health facility.
FGD were conducted with grandmothers, men, and women living in the
surrounding communities of the health facilities. The study team approached
community based organizations or community leaders in these areas and
informed them of the study. They identified and informed possible participants of
the study and coordinated the meeting for the focus group at a time and place
convenient for the participants. Investigators used structured interview and FGD
guides consisting of questions on knowledge, perceptions, attitudes and behavior
regarding HIV testing for partners of pregnant women, either within MCH
services or other services at the health facility. Vignettes with hypothetical
scenarios were used during the discussions.
The interviews and FGD were conducted in Portuguese or Changana.
Audiotapes and notes were translated to Portuguese and entered in Microsoft
Word. Transcripts were manually coded by two researchers independently. The
results were compared and discrepancies were discussed until consensus was
reached. Analysis was done using MAXqda Version 10 (Verbi GmbH, Berlin,
Germany). Deductive codes originated from the research questions, and inductive
codes emerged from the data. Data displays with coded responses by participant
group for each code were developed and compared. Data reduction was
conducted through detailed matrices on each theme [12]. Descriptive analysis of
participants’ demographic data was done with STATA Version SE/11.0
(StataCorp, Texas, USA).
The Mozambique National Health Bioethics Committee (CNBS, Comite´
Nacional de Bioe´tica para Sau´de) in Mozambique reviewed and approved the
study. Study staff obtained written informed consent from all participants in
Portuguese or in the local language (Changana) before enrollment.
Results
Characteristics of the study population
A total of 1230 pregnant women were enrolled in the cohort with 151 (12%) lost
to follow-up (LFU) after the enrollment visit and an additional 188 (15%) as they
missed their last study visit at delivery (Fig. 1). The median follow up time for 968
women who had at least one follow up visit was 124 days (IQR 76–141). Baseline
characteristics of the cohort are shown in Table 1. The median age at enrollment
was 24 years (IQR 20–29) with a median gestational age of 24 weeks (IQR 21–28).
This was the first pregnancy for 196 (16%) women.
At enrollment, 229 (19%) of the women reported that their partner was tested
for HIV, 685 (56%) reported that their partner was not tested for HIV and 232
(19%) reported not knowing if their partner was ever tested. Of the 229 women
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who reported to know that their partner was ever tested for HIV, 213 (93%)
reported to know the test result. Eight of them said their partner was HIV positive.
There was no difference among women with and without follow-up visits.
Reported serodiscordancy (male+/female2) at enrollment was 4% (8/213).
Among those eight discordant couples, five women (63%) reported never using
condoms with their partner, two (25%) reported that they sometimes do and one
(12%) reported that they always do. Overall, 79% of women reported that they
never used a condom with their partner.
During the study follow-up, 62 (9%) partners of women who reported that
their partner was not previously tested, received HIV testing, while 76 (37%)
partners of those who reported that their partner was tested and HIV negative,
were retested. In both groups, none of the partners tested positive. Similarly, 25
(11%) partners of women who did not know if their partners had been tested were
subsequently tested, with a positive HIV test result in two (8%). Information
about sexual activity during the study period was provided by 494 women: 220
women reported not having had sexual activity with their partner, while 274
reported having had sex with their partner. Extramarital sexual activity during
pregnancy was reported by 80 women, of whom 2 declared to have had sexual
activity outside the marriage during the study period. Among participants who
responded about partner extramarital sexual activity, 35% (77/221) of their
partners had extramarital sexual activity during the study period.
Women who were lost from the study after enrollment visit were more likely
than women with study follow-up to be from Gaza Province (72% versus 46%;
p50.0001), have a gestational age .23 weeks at enrollment (73% versus 61%;
Fig. 1. Flowchart of the cohort study. Study visits were scheduled at enrollment, 28 weeks of gestational age (visit 2), and delivery (visit 3). Women
enrolled at gestational age ,28 weeks (n5855) had three scheduled visits. Women who enrolled between 28 and 32 weeks of gestational age (n5360)
participated in only two of the three study visits (enrollment visit and delivery). Fifteen women enrolled at a gestational age between 0–32 weeks, but exact
age was not known. SC seroconversion; HIV – HIV negative; LFU lost to follow-up.
doi:10.1371/journal.pone.0115014.g001
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Table 1. Baseline characteristics of the study population (n51230).
Total (n)
Percentage/median
(IQR)
1230
Province
Maputo 591 48%
Gaza 639 52%
Age (years) 1201 24 (20–29)
Missing 29
First pregnancy/subsequent pregnancy
First pregnancy 196 16%
Subsequent pregnancy 971 79%
Missing 63 5%
Gestational age at inclusion (weeks)
10–23 weeks 431 35%
24–32 weeks 784 64%
Missing 15 1%
Parity
,3 763 62%
$3 404 33%
Missing 63 5%
Age at first child (years)
Median (IQR) 1123 18 (17–20)
Missing 107
Marital status
Married/living with partner 820 67%
Relationship but not living with partner 132 11%
Divorced/separated/widow/single 275 22%
Missing 3 0%
Polygamous marriage (out of the married couples)
No 632 77%
Yes 127 15%
Missing 61 7%
Educational level
,Primary education 819 67%
Complete primary education or more 400 33%
Missing 11 1%
Partners’ educational level
,Primary education 537 44%
Complete primary education or more 482 41%
Missing 211 17%
Knowledge if partner was ever tested for HIV, at baseline
Not tested 685 56%
Tested and HIV negative 205 17%
Tested and HIV positive 8 1%
Tested but don’t know result 16 1%
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p50.001), be single (38% vs 18%; p,0.0001), have less than complete primary
education (74% versus 65%; p50.001) and have a partner with less education
(50% versus 42%; p50.008).
HIV incidence and associated risk factors
During the follow up period, 14 new HIV infections were detected by HIV rapid
testing, seven at the second study visit and seven at time of delivery. On
confirmatory HIV DNA-PCR testing, all of the samples of the time of
seroconversion were positive. Eleven out of the 13 cases were found to be DNA-
PCR positive at enrollment; one sample of the enrollment visit was missing.
Total follow up was 328 women years. HIV incidence in the cohort is calculated
at 4.28 per 100 women-years (95% CI: 2.33–7.16). Only one woman with
seroconversion had a partner known to be HIV positive at enrollment; five
partners were reported to be HIV negative and eight partners were of unknown
serostatus. Only one partner of a newly infected woman was reported to have been
retested during study follow-up (HIV negative), one partner was known not to be
retested and in 11 it was not known if retested.
Analysis of potential risk factors associated with HIV seroconversion in
univariate analyses are shown in Table 2. The only significant associations seen
were a 4-fold increased risk among women living in Maputo (p50.05) and
women with sexual debut before 17 years of age (p50.04).
There was a marginally significant higher HIV incidence rate among women
who knew their partners’ HIV status compared to those who did not know their
Table 1. Cont.
Total (n)
Percentage/median
(IQR)
1230
Don’t know if tested 232 19%
Missing 84 7%
Condom use ever with the current partner
Never 974 79%
Sometimes 225 18%
Always 9 1%
Missing 22 2%
Ever had extramarital sexual activity before enrollment
No 1162 95%
Yes 27 2%
Missing 41 3%
Knowledge if partner ever had extramarital sexual activity before enrollment
No 450 36%
Yes 192 16%
Don’t know 588 48%
doi:10.1371/journal.pone.0115014.t001
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Table 2. Risk ratios for socio-demographic, sexual behavior and knowledge risk factors among women with follow-up (n5968).
Number Number SC Risk Ratio (95% CI)
P-
value1
1. SOCIODEMOGRAPHIC RISK FACTORS
Province
Maputo 518 12 4.35 (0.97–19.45) 0.05
Gaza 450 2 Reference
Age (years) 942 0.94 (0.83–1.05)2 0.282
First/Subsequent pregnancy
First pregnancy 163 4 Reference
Subsequent pregnancy 757 10 0.62 (0.19–1.98) 0.42
Gestational age at enrollment
10–23 weeks 361 3 Reference
24–32 weeks 594 11 3.25 (0.91–11.64) 0.07
Marital Status
Married/living with partner 677 11 Reference
Relationship but not living with partner 114 2 1.02 (0.23–4.59) 0.98
Divorced/separated/widow/single 175 1 0.32 (0.04–2.44) 0.27
Polygamous marriage (out of the married couples)
No 519 6 Reference
Yes 106 2 1.78 (0.36–8.82) 0.48
Educational level
,Primary education 625 8 Reference
Complete primary education or more 339 6 1.28 (0.44–3.68) 0.65
Partner Educational level
,Primary education 406 2 Reference
Complete primary education or more 397 9 4.09 (0.88–18.94) 0.07
Employment status participant
No 750 10 Reference
Yes 68 2 2.38 (0.52–10.88) 0.26
Employment partner
No job 181 1 Reference
Employee 174 5 4.67 (0.55–4.00) 0.16
Own business/sales 132 2 2.62 (0.24–28.93) 0.43
Mineworker 242 3 2.48 (0.26–23.73) 0.43
Other 229 3 2.22 (0.23–21.44) 0.49
Absence of partner at least one continuous month
No 594 11 Reference
Yes 336 3 0.55 (0.15–1.97) 0.36
2. SEXUAL BEHAVIOR RISK FACTORS
Age at first sexual activity (years)
,516 years 406 10 3.79 (1.04–13.78) 0.04
17–27 years 422 3 Reference
Ever tested for HIV prior to this pregnancy
No 507 7 Reference
Yes 397 7 1.34 (0.47–3.82) 0.55
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partners’ HIV status (p50.055). Of note, 171 reported that their partner was HIV
negative and 6 partners were HIV positive. Trends were also seen in higher risk for
women with more educated partners (RR 4.09 [95% CI: 0.88–18.94], p50.07) and
women with higher gestational age at enrollment (RR 3.25 [95% CI: 0.91–11.64],
p50.07).
Table 2. Cont.
Number Number SC Risk Ratio (95% CI)
P-
value1
Knowledge of partners’ HIV status at baseline
Do not know partners’ status 177 6 Reference
Know partners’ status 729 8 2.82 (0.98–8.13) 0.055
Serodiscordancy at baseline
Partner HIV negative 171 5 Reference
Partner HIV positive 6 1 3.85 (0.45–32.99) 0.22
Condom use ever with the current partner
Never 761 12 Reference
Sometimes 186 1 0.29 (0.04–2.22) 0.23
Always 9 1 8.10 (1.05–62.31) 0.04
Ever had extramarital sexual activity before enrollment
No 926 13 Reference
Yes 19 1 3.94 (0.52–30.12) 0.19
Knowledge if partner ever had extramarital sexual activity before enrollment
No, he had not 322 2 Reference
Yes, he had 159 0 3.3 e-8 (0-) .0.999
Don’t know if he had 487 12 3.28 (0.73–14.64) 0.12
3. KNOWLEDGE RISK FACTORS
Identification of VT risk during pregnancy
No 328 7 Reference
Yes 538 6 0.57 (0.19–1.71) 0.32
Identification of VT risk during delivery
No 451 9 Reference
Yes 415 4 0.53 (0.16–1.73) 0.29
Identification of VT risk during breastfeeding
No 162 2 Reference
Yes 704 11 1.12 (0.25–5.05) 0.88
Is there cure for HIV
No 678 12 Reference
Yes 124 1 0.51 (0.07–3.91) 0.52
Don’t know or no response 102 1 0.51 (0.07–3.96) 0.52
SC5 seroconversion; VT5 vertical transmission.
1p-values from bivariable Poisson regression models (i.e., generalized linear models using the Poisson distribution with the log link and an offset accounting
for person-years).
2Risk ratio for a age compares two groups that differ by one year.
Boldface 5 statistically significant (p,0.05).
doi:10.1371/journal.pone.0115014.t002
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Motivators and Barriers to male partner HIV testing
Between August and November 2011, individual interviews were conducted in the
selected study facilities with 15 men, 10 women and 12 nurses. Additionally, 11
FGD were held: three with 22 men, four with 35 women, and four with 36
grandmothers. One woman with a three year old child participated in a FGD
although she was outside of the eligible postpartum period. Characteristics are
available for all but the HCW (Table 3) and a summary of barriers and motivators
are presented in Table 4.
a. Barriers of uptake of HIV testing
One of the most important barriers is fear of discrimination or stigma, which was
reported by all groups except HCW. During the interviews and FGD, the fear of
women losing their home was mentioned frequently as a barrier for women to test,
disclose or invite their husbands for testing. Men and women said that men don’t
want to get tested for fear of a positive test result.
‘‘It can also happen that he is scared to be seen by somebody in the health center
who will go and spread in the area where he lives that he is in that situation
(meaning being HIV positive)’’ (Focus Group Discussion, Moamba, Men)
One barrier related to knowledge about HIV testing that was mentioned by
some women is that male partners assume they have the same test result as their
female partner (in this case the pregnant woman) or child, which makes it
unnecessary for them to go for HIV testing.
‘‘Sometimes, you can go and do the test, and they say you are negative; you come
to say to him you did the test and is negative, he says: so I am also negative, I
don’t need to go there any more’’ (Focus Group Discussion, Boane, Women)
Some HCW indicated that the MCH environment is not male friendly and not
conducive to attending to men or couples. Some men felt that women are offered
various (MCH) services while there is no motivation/reason for men to go,
considering those services as a ‘‘place for women’’. Cultural taboos or rituals cause
people/men not to go for HIV testing to a health facility, such as men not being
allowed to see women’s blood. This was mentioned by most HCW.
‘‘Taboo such as for example the man that cannot see the woman’s blood, so she
can’t go with her husband to the hospital; only mothers-in-law go who are also
women’’(Individual Interview, Moamba, HCW)
Other barriers include distance to the health facility or the partner being absent
(working as a migrant worker in South-Africa). Men indicated that they don’t
have time.
b. Motivators of uptake of HIV testing
All groups except HCW said that men (and women) are motivated to get tested
because they know the importance of getting tested and starting treatment early if
needed.
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‘‘People do the test, because they want to know about their health’’ (Individual
Interview, Chicumbane, Women)
In contrast to above, about half of the men and women knew that it is necessary
to get tested for themselves, as they cannot assume their results are the same as
their partners’ or infants’. Some of the men said that they would accept an
invitation to go for HIV testing if it was given to them.
Grandmothers indicated that the health facility is the right place to go for HIV
testing and care. They frequently mentioned that support from the family (in
Table 3. Characteristics of participants of the qualitative study (n5118).
Men Women Grandmothers Total
37 45 36 118
Age (years, median, IQR) 42 (30–56) 26 (22–32) 55 (50–60)
Educational level
,Primary education 24 24 34 82
Complete primary education or more 13 21 2 36
Marital status
Married/Living with partner 35 30 20 85
Divorced/separated/widow/single 2 15 16 27
Parity
,3 19 21 8 48
$3 18 24 28 70
Age of youngest child (years, median (IQR) (for parents only)
4 (1.3–8) 0.9 (0.3–1.8)
Pregnancy (for women only)
Not pregnant 42
Pregnant 3
doi:10.1371/journal.pone.0115014.t003
Table 4. Summary of barriers, motivators of accessing HIV testing by male partners.
Barriers Motivators
Knowledge - Assume test result of partner or child is the same so no
need to go for HIV testing
- You can’t assume partner or child result
- Knowing the importance of getting tested (wanting to
know status) and treated early
Perceptions - Health facility is a place for women only - Health facility is the right place for HIV testing and care
Behavior/attitude - Fear of stigma and discrimination - Family and community support
- Fear of disclosure - Would go to health facility if invitation was given
- Cultural taboos/rituals
Other - Absence (migrant worker) - Priority for couples at MCH services
- Men don’t have time
- Services not male-friendly
MCH – Mother and Child Health.
doi:10.1371/journal.pone.0115014.t004
HIV Seroconversion and Partner Testing during Pregnancy in Mozambique
PLOS ONE | DOI:10.1371/journal.pone.0115014 December 26, 2014 12 / 17
most cases themselves giving support to a son and daughter-in-law) and
community helps men to adhere to HIV testing services.
‘‘Because she will be scared to tell her husband, say it to me and I will join them
and say to my son that your wife delivered and had this and that, and go with
your wife to get examined so you can get similar medication as your wife.’’ (Focus
Group Discussion, Chibuto, Grandmothers)
HCW noted that men and couples get priority at MCH services, and the
resulting decrease in waiting time is a facilitator for male HIV testing.
Participants recommended more counseling and testing at the community
level, including ‘‘health campaigns’’, home based counseling and testing,
sensitization sessions directed at men, and strong involvement of community
leaders and community health workers. At the health facility, a more men-friendly
approach was suggested by some men, women and HCW: creation of a men-
friendly room at MCH, flexible opening hours to accommodate men’s working
hours and invitations sent out by the health facilities.
Discussion
This study identified a high HIV incidence rate (4.28 per 100 women-years) in a
population of pregnant women in Southern Mozambique, similar to other
countries in the region [11, 13–17]. This incidence during pregnancy is higher
than that seen in a cohort followed in the same facilities from delivery to 18
months postpartum (3.2 per 100 women-years) [10]. However, a recent meta-
analysis on HIV incidence during pregnancy and postpartum did not show
significant differences in the pooled incidence rates during pregnancy compared
to postpartum period (4.7 per 100 women-years during pregnancy versus 2.9 per
100 women-years during the postpartum period) [2]. This cohort of pregnant
women in Southern Mozambique had similar high incidence rates to sexually
active women in the southern region (4.6 per 100 women-years) and slightly lower
than in the central region in a study involving women with multiple sexual
partners in the last month (6.5 per 100 women-years) [18, 19]. In these settings,
major investments should be directed at primary prevention strategies for all
women in reproductive age.
The HPTN052 study, conducted among stable discordant couples, demon-
strated the importance of identifying discordant couples and early initiation of
ART to prevent transmission within the couple [20]. However, it also found that
18% of the HIV transmissions were not linked to the partner [20], indicating that
focusing efforts on the partner alone may not be sufficient to address the challenge
of seroincidence in pregnancy. Besides the possible biological reasons for a higher
susceptibility among pregnant women, risk behaviors should not be forgotten as
an important factor [2, 13]. Our study results showed that some women reported
extramarital sexual activity during pregnancy. Increased HIV risk behaviors
during pregnancy have been seen for example in Mpumalanga, South Africa,
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where 20% of pregnant women declared having at least 2 sexual partners in the
last 3 months [21]. Studies on risk behavior among partners of pregnant women
are scarce. Our findings show that 35% of the women reported that their partner
had an extramarital sexual relationship during the study period. This is higher as
in the neighbouring country South-Africa where 18% of the male partners had sex
with somebody else than the pregnant partner in the previous month [22].
Partner testing remains extremely low in sub-Saharan Africa, usually between
10 and 16% [7, 23, 24]. Our study revealed that 19% of the pregnant women
reported to know that their partner was ever tested, slightly higher than those
reports. Not testing among couples increases the chance of unknown
serodiscordancy, with a higher risk of HIV acquisition and vertical transmission.
The Mozambique national HIV survey showed a serodiscordant rate of 10% with
half being male positive discordance [9], which is a similar result to what we
found among pregnant couples (4%). Knowing the partners’ HIV status resulted
in a higher risk of seroconversion in our study, even though the majority reported
HIV negative partners. This could be due to reporting bias, unlinked seroincident
infections in the partner with subsequent transmission to the pregnant women, or
a false feeling of security when the couple receives an initial negative HIV result.
The barriers to partner testing identified in the qualitative study point to several
alternative strategies to increase HIV testing among partners. Priority is given to
men when accompanying their partners to MCH, however this has not resulted in
significant testing. Initiatives to attract men to health facilities by creating more
men-friendly services, or provision of mobile health prevention services for men
are needed. Another suggestion from participants was to move the counseling and
testing to the community. Community testing is part of the Mozambique Ministry
of Health’s program, but it does not focus on pregnant women and their families.
Expansion of health prevention and care services to the community could play
a critical role in improving access to reproductive health care services for men,
women, adolescents and couples. Home based couple testing has been seen as
acceptable but issues such as stigma and disclosure need to be addressed, and
counselors should be appropriately trained [25]. A study done in Uganda suggests
an increase in HIV testing when done at the households [26] and success has been
seen with community intervention packages with a couple centered approach for
MCH/PMTCT services [27, 28]. A recent review showed that non-health facility
initiatives lead to higher male involvement than facility based initiatives [29].
Other primary prevention activities directed to men at workplace, including
mining companies, should be strengthened as they might be more accessed by
men than primary health care services.
The strength of our study is that seroconversion was measured within a cohort
study, giving the most reliable information on new HIV infections. Limitations
include a high loss to follow-up, which limited multivariate and longitudinal
analyses. Women lost after enrollment differed from those followed in some
characteristics, which may have led to underestimated incidence results (e.g.
province and partner level of education). This was an operational research study
where women were tested for HIV using the national algorithm of rapid assays in
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all study visits. The operational nature of the study did not permit the testing of
all enrolled women with a molecular assay. For study purposes, stored DBS
specimens from women who seroconverted to positive on standard rapid HIV
testing were tested using HIV DNA PCR (13 tested out of 14 seroconverters). We
found that 10 of these 13 women with a negative HIV rapid assay on the initial
visit were positive on DNA-PCR testing. Conversely, it is also possible that women
with a negative HIV rapid test on the last study visit were infected with HIV but
still undetected with an antibody assay. Since the difference in the diagnostic
window between rapid antibody and molecular assays are usually around 7–10
days and as detected seroconversions were equally distributed across the study
visits, it is plausible that true new infections were equally prevalent, with little
impact on the incidence rates described here. Therefore, we used seroconversion
as a proxy for seroincidence. As in all surveys, there is a risk of reporting bias on
information given regarding individual and partner’s sexual behavior. Data on
vertical transmission were not available for women in this study.
HIV incidence during pregnancy is high and partner HIV testing is low in
Southern Mozambique, emphasizing the urgent need for increased support for
primary prevention within MCH services. Reaching men for HIV testing,
prevention and/or treatment is crucial. Knowledge of both partners’ HIV status is
critical for maximum effectiveness of prevention and treatment services to reach
elimination of pediatric HIV/AIDS.
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